Cell Signaling Technology

ERC1 (P85) Antibody

#2884 · $317

100
Citing papers
14.3k
Combined citations
Supplier page Find this product

Research areas

MicroRNA in disease regulation17Cancer-related molecular mechanisms research12RNA modifications and cancer9Circular RNAs in diseases8PI3K/AKT/mTOR signaling in cancer8Alzheimer's disease research and treatments5Mesenchymal stem cell research5RNA Research and Splicing5

Papers citing this product

1
Pten Dose Dictates Cancer Progression in the Prostate
PLoS Biology·2003·667 cit.·DOI
2
Intraparticle Molecular Orbital Engineering of Semiconducting Polymer Nanoparticles as Amplified Theranostics for <i>in Vivo</i> Photoacoustic Imaging and Photothermal Therapy
ACS Nano·2016·503 cit.·DOI
3
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
Journal of Clinical Investigation·2008·387 cit.·DOI
4
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
Molecular Cancer·2020·377 cit.·DOI
5
Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation
Journal of Biological Chemistry·2018·359 cit.·DOI
6
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
Nature Communications·2017·333 cit.·DOI
7
Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping
Nature·2020·330 cit.·DOI
8
Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage
Cell Death and Differentiation·2002·321 cit.·DOI
9
Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells
Nature Communications·2018·318 cit.·DOI
10
Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-γ
EBioMedicine·2018·285 cit.·DOI